Ketanserin
- Generic Name
- Ketanserin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C22H22FN3O3
- CAS Number
- 74050-98-9
- Unique Ingredient Identifier
- 97F9DE4CT4
- Background
Ketanserin has been investigated for the treatment of Septic Shock, Severe Sepsis, and Diabetic Foot Ulcer.
- Associated Conditions
- -
- Associated Therapies
- -
Effect of Ketanserin After LSD Administration
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-09-22
- Last Posted Date
- 2021-10-21
- Lead Sponsor
- University Hospital, Basel, Switzerland
- Target Recruit Count
- 24
- Registration Number
- NCT04558294
- Locations
- 🇨🇭
Clinical Pharmacology & Toxicology, University Hospital Basel, Basel, Switzerland
Ketanserin Effects on Peripheral Temperature and Lactate
- First Posted Date
- 2018-08-24
- Last Posted Date
- 2018-08-24
- Lead Sponsor
- Onze Lieve Vrouwe Gasthuis
- Target Recruit Count
- 120
- Registration Number
- NCT03646318
The Neurobiological Effect of 5-HT2AR Modulation
- First Posted Date
- 2017-09-21
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Gitte Moos Knudsen
- Target Recruit Count
- 200
- Registration Number
- NCT03289949
- Locations
- 🇩🇰
Neurobiology Research Unit, Rigshospitalet, Copenhagen, Denmark
Efficacy of Pirfenidone Plus MODD in Diabetic Foot Ulcers
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-12-17
- Last Posted Date
- 2015-12-17
- Lead Sponsor
- University of Guadalajara
- Target Recruit Count
- 60
- Registration Number
- NCT02632877
- Locations
- 🇲🇽
Molecular Biology and Gene Therapy Institute, Guadalajara, Jalisco, Mexico
🇲🇽Hospital Valentín Gómez Farías, Zapopan, Jalisco, Mexico
The Role of 5-HT2A Receptor in the Perception of Self and Personal Meaning in Healthy Volunteers
- First Posted Date
- 2015-05-21
- Last Posted Date
- 2016-02-01
- Lead Sponsor
- Psychiatric University Hospital, Zurich
- Target Recruit Count
- 25
- Registration Number
- NCT02451072
- Locations
- 🇨🇭
Center for Psychiatric Research, Department of Psychiatry, Psychotherapy and Psychosomatic, Psychiatric Hospital, University of Zurich, Zurich, Switzerland
The Effect of Ketanserin on the Microcirculation in Sepsis
- First Posted Date
- 2011-04-06
- Last Posted Date
- 2014-05-09
- Lead Sponsor
- Medical Centre Leeuwarden
- Target Recruit Count
- 10
- Registration Number
- NCT01329887
- Locations
- 🇳🇱
Medical Centre Leeuwarden, Leeuwarden, Netherlands
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath